AASLD News

As the global burden of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) continues to rise, AASLD remains at the forefront by providing members with the latest evidence, expert insights, clinical guidance, and educational resources to support the prevention, diagnosis, and treatment of MASLD and MASH. Join the conversation

New program empowers the medical community at the point of care to improve patient outcomes and change the trajectory of liver disease. ALEXANDRIA, VA – The American Association for the Study of Liver Diseases (AASLD) recently launched the Liver Care for Frontline Clinicians program, advancing its mission to treat and cure liver disease by extending its scientific leadership and equipping point-of

Alexandria, VA – June 5, 2026 – The American Association for the Study of Liver Diseases (AASLD) proudly announces the 2026 Distinguished Award recipients, honoring individuals whose outstanding contributions have shaped the field of hepatology and advanced the care of patients with liver disease. Each year, AASLD presents its most prestigious awards to recognize exceptional leadership, mentorship

ALEXANDRIA, Virginia — AASLD is excited to announce the 2026 Editorial Fellows for HEPATOLOGY and Liver Transplantation. Designed to help cultivate the next generation of leaders in academic publishing, this year-long fellowship offers an immersive opportunity to work alongside experienced journal editors and gain behind-the-scenes insight into the editorial processes that shape leading hepatology

Alexandria, VA – May 26, 2026 – The American Association for the Study of Liver Diseases (AASLD) is pleased to announce two new multinational consensus statements, published today in HEPATOLOGY, the premier publication in the field of liver disease. Developed through broad international collaboration, these statements provide critical guidance and help advance global alignment in hepatology

AASLD is proud to announce the 2027 leadership for the AASLD Governing Board and the AASLD Foundation Board of Trustees! These distinguished leaders bring expertise, strategic vision, and a deep dedication to advancing the field of hepatology. Their leadership will help guide AASLD and the AASLD Foundation as we continue to drive innovation, support groundbreaking research, and shape the future of

New $500,000 Stravitz Visionary Award and inaugural AASLD Impact Award strengthen support for discovery, innovation, and recognition across the hepatology community. At DDW ® 2026, AASLD and the AASLD Foundation announced two major new initiatives designed to advance the future of hepatology through strategic investment in scientific discovery and recognition of professional achievement. Together

April is National Donate Life Month. It’s a time to recognize the life-saving impact of organ donation to honor the patients, families, clinicians, and researchers who make liver and other organ transplantation possible. Transplantation is not only a clinical milestone, it’s a lifelong journey shaped by resilience and deep gratitude. While advances in science and care continue to improve outcomes

Award-winning project advances evidence-based care through member-driven innovation Alexandria, VA – April 13, 2026 – The American Association for the Study of Liver Diseases (AASLD) recently announced Marina Serper, MD, MS, FAASLD as the inaugural recipient of the AASLD Project Innovation Award. Launched in 2025 and supported by a generous anonymous donor through the AASLD Foundation, the Project

AASLD is proud to recognize Marina Serper, MD, MS, FAASLD as the inaugural recipient of the AASLD Project Innovation Award, marking a milestone moment in advancing member-driven innovation across the field of hepatology. An Associate Professor of Medicine at the University of Pennsylvania and transplant hepatologist, Dr. Serper holds deep expertise in epidemiology, health services and patient

Expert panel will develop consensus recommendations to reduce barriers to identifying liver fibrosis in at-risk populations. Alexandria, VA — [March 23, 2026] — The American Association for the Study of Liver Diseases (AASLD) is pleased to announce a new national initiative to advance early detection of liver fibrosis and reduce barriers to identifying liver disease among individuals at risk for

Alexandria, VA – March 18, 2026 — The American Association for the Study of Liver Diseases (AASLD) supports a recent federal court ruling that temporarily blocks proposed changes to the U.S. immunization schedule, preserving access to the universal hepatitis B birth dose and routine childhood hepatitis A vaccination. The decision, issued March 16, halts implementation of changes that threatened to

The American Association for the Study of Liver Diseases (AASLD), the leading organization of scientists and health care professionals committed to preventing and curing liver disease, is pleased to announce the selection of 33 hepatology leaders as Fellows and six hepatology-focused clinicians as Associate Fellows. The Fellows program (FAASLD) bestows honorary recognition to AASLD Regular and

AASLD recently submitted formal comments to the U.S. Department of Education opposing a proposed rule that would exclude nurse practitioner (NP) and physician assistant (PA) degrees from classification as professional degrees for support from federal student loan programs. While this proposal may appear administrative in nature, its implications for the hepatology workforce and for patients living